WASHINGTON STRATEGIC CONSULTING

Lobbying for CENTRASTATE HEALTHCARE SYSTEM · hospital and health system

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 13, 2025.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 13, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Cybersecurity, including S. 4054, the Healthcare Cybersecurity Improvement Act of 2024, 340B Drug Pricing Program, Site-neutral payment policy proposals, including the Lower Costs, More Transparency Act (H.R. 5378), Telehealth Modernization Act of 2023 (H.R. 7623), Medicaid Disproportionate Share Hospital Cuts, FEMA payment of COVID-19 provider payments, Reauthorization of the All-Hazards Preparedness Act, Medicare Advantage prior authorization

Bills named in this filing 3

S. 4054
Health Care Cybersecurity Improvement Act of 2024
H.R. 5378
Lower Costs, More Transparency Act
H.R. 7623
Telehealth Modernization Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.